TB
The startup has developed a blood testing tool that detects coronary artery disease (CAD) by measuring immune imbalances in blood samples with high precision. This technology enhances diagnostic accuracy, broadens access to previously unreachable patient populations, and minimizes the need for multiple costly and invasive tests.
Updated 3 months ago
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a blood testing tool that detects coronary artery disease (CAD) by measuring immune imbalances in blood samples with high precision. This technology enhances diagnostic accuracy, broadens access to previously unreachable patient populations, and minimizes the need for multiple costly and invasive tests.